Clinical significance of cardiac troponins I and T in acute heart failure

European Journal of Heart Failure

Volumn 10, Issue 8, 2008, Pages 772-779

  Ilva, Tuomo ^a   Lassus, Johan ^b   Siirilä Waris, Krista ^b   Melin, John ^c   Peuhkurinen, Keijo ^d   Pulkki, Kari ^e   Nieminen, Markku S ^b   Mustonen, Harri ^b   Porela, Pekka ^f   Harjola, Veli Pekka ^b  

^a KANTA HÄME CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Central Finland Central Hospital   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Acute heart failure; Prognosis; Troponin I; Troponin T

Indexed keywords

CYSTATIN C; TROPONIN I; TROPONIN T;

ACUTE HEART FAILURE; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; VALVULAR HEART DISEASE;

AGED; BLOOD PRESSURE; FEMALE; HEART FAILURE; HUMANS; MALE; MYOCARDIUM; PROGNOSIS; PROSPECTIVE STUDIES; TROPONIN I; TROPONIN T;

EID: 46849116888     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.06.009     Document Type: Article

References (26)

1. Adams K.F., and Zannad F. Clinical definition and epidemiology of advanced heart failure. Am Heart J 135 (1998) S204-S215
2. O'Connell J.B. The economic burden of heart failure. Clin Cardiol 23 (2000) III6-III10
3. Goldberg R.J., Ciampa J., Lessard D., Meyer T.E., and Spencer F.A. Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med 167 (2007) 490-496
4. Horwich T.B., Patel J., MacLellan W.R., and Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003) 833-838
5. Hudson M.P., O'Connor C.M., Gattis W.A., et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 147 (2004) 546-552
6. Perna E.R., Macin S.M., Canella J.P., et al. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation 110 (2004) 2376-2382
7. Miller W.L., Hartman K.A., Burritt M.F., et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 116 (2007) 249-257
8. Perna E.R., Macin S.M., Cimbaro Canella J.P., et al. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. Int J Cardiol 99 (2005) 253-261
9. Metra M., Nodari S., Parrinello G., et al. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail 9 (2007) 776-786
10. Lassus J., et al., for the FINN-AKVA Study group. Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J 28 (2007) 1841-1847
11. James S., Flodin M., Johnston N., Lindahl B., and Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem 52 (2006) 832-837
12. Apple F.S., Murakami M.M., Pearce L.A., and Herzog C.A. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106 (2002) 2941-2945
13. Brunet P., Oddoze C., Paganelli F., et al. Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome. Int J Cardiol (2007) [Electronic publication ahead of print]
14. Siirila-Waris K., Lassus J., Melin J., Peuhkurinen K., Nieminen M.S., Harjola V.P., et al. FINN-AKVA Study Group. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 27 (2006) 3011-3017
15. Parmacek M.S., and Solaro R.J. Biology of the troponin complex in cardiac myocytes. Prog Cardiovasc Dis 47 (2004) 159-176
16. Korff S., Katus H.A., and Giannitsis E. Differential diagnosis of elevated troponins. Heart 92 (2006) 987-993
17. Goser S., Andrassy M., Buss S.J., et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 114 (2006) 1693-1702
18. Wu A.H. Cardiac troponin: friend of the cardiac physician, foe to the cardiac patient?. Circulation 114 (2006) 1673-1675
19. Shmilovich H., Danon A., Binah O., et al. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Int J Cardiol 117 (2007) 198-203
20. K.H. Miettinen, S. Eriksson, J. Magga, et al. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy. J Card Fail, in press.
21. Perna E.R., Macin S.M., Cimbaro Canella J.P., et al. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. J Heart Lung Transplant 25 (2006) 1230-1240
22. Sakhuja R., Green S., Oestreicher E.M., et al. Amino-terminal pro-brain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heart failure. Clin Chem 53 (2007) 412-420
23. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 21 (2000) 1502-1513
24. Apple F.S., et al., National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation 116 (2007) e95-e98
25. Thygesen K., Alpert J.S., White H.D., and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 28 (2007) 2525-2538
26. Latini R., et al., Val-HeFT Investigators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 116 (2007) 1242-1249